Tag: Novartis

Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market cap and sales.

Tilray set up a strategic alliance with a leading Canadian pharma company

medicinal cannabis
Tilray, a licensed producer of medical cannabis, signed a binding letter of intent to be the collaborator of a major pharma company to accelerate innovation and increase availability of high quality medical cannabis products.

Novartis advances its clinical trials program with Science 37

Novartis announced an additional strategic alliance with Science 37, a leader in decentralized clinical trial technology and design, to initiate up to 10 new clinical trials over the next three years.

Novartis is involved in Greek bribe scandal

Greece's parliament has linked ten prominent politicians to a bribery scandal involving Swiss healthcare company Novartis. The Greek parliament announced on Tuesday the results of a judicial investiga...

Novartis exclusively licensed gene therapy drug

Novartis announced a licensing agreement with Spark Therapeutics covering development, registration and commercialization rights to voretigene neparvovec in markets outside the US

AIPM elects Vadim Vlasov as Chairman of its Board of Directors

The Association of International Pharmaceutical Manufacturers announced that Vadim Vlasov, the President of Novartis Group Russia, was elected the Chairman of AIPM Board of Directors

Novartis plans to buy French radiopharmaceutical company

Global healthcare company Novartis has announced plans to acquire Advanced Accelerator Applications, a radiopharmaceutical firm established by physicist Stefano Buono in 2002

FAS of Russia identified unjustified 35% overpricing of Tyverb

FAS Russia
In April 2017, the FAS Russia initiated a case on the grounds that Novartis Pharma had violated Clause 1 of Part 1 of Article 10 of the Law on Protection of Competition

Commercial manufacturing was launched at Novartis Neva plant

The Vice-Governor of St. Petersburg and The President of Novartis Group in Russia launched the commercial manufacturing of Ketonal® DUO

Russian pharmaceutical market reaches 863 billion rubles in Q1-Q3

According to AlphaRM, September 2017 ended with the growth in the retail segment and fall in the public segment of the pharmaceutical market

Novartis and Homology Medicines started R&D collaboration

Homology Medicines announced today that it entered into a research and development collaboration with Novartis

Novartis, Geropharm and Orion Medic plan to start industrial-scale manufacturing

Novartis, Geropharm and Orion Medic plan to start commercial serial production of some of their medicinal products and equipment in St. Petersburg before the end of this year

Novartis intends to aquire radiopharmaceutical company

Novartis entered a memorandum of understanding with Advanced Accelerator Applications under which Novartis intends to commence a tender offer

European Comission approved Novartis cancer drug

Novartis today announced that the European Commission approved Rydapt (midostaurin) for two indications in rare, hard-to-treat cancers

FDA approved first cancer gene therapy from Novartis

fda office
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States

Novartis tests the new compound against drug-resistant malaria

Novartis and Medicines for Malaria Venture have launched a patient trial for KAF156

Rydapt by Novartis received positive CHMP opinion

Last Friday Novartis announced that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending approval of Rydapt